Agilent Technologies Inc (A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Agilent Technologies Inc (A) has a cash flow conversion efficiency ratio of 0.057x as of July 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($362.00 Million) by net assets ($6.37 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Agilent Technologies Inc stock valuation for the company's overall valuation and market capitalisation.
Agilent Technologies Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Agilent Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Agilent Technologies Inc ranked by their cash flow conversion efficiency. Explore Agilent Technologies Inc cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STMicroelectronics N.V
F:SGMR
|
0.029x |
|
Banco Bradesco DRC
BA:BBD
|
0.005x |
|
Shanghai Pudong Development Bank Co Ltd
SHG:600000
|
0.372x |
|
Humana Inc
NYSE:HUM
|
-0.022x |
|
Coca-Cola European Partners PLC
NASDAQ:CCEP
|
0.116x |
|
RIO Tinto Ltd
AU:RIO
|
0.151x |
|
Samsung Biologics Co Ltd
KO:207940
|
0.075x |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
0.049x |
Annual Cash Flow Conversion Efficiency for Agilent Technologies Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Agilent Technologies Inc from 1998 to 2025. View A share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | $6.74 Billion | $1.56 Billion | 0.231x | -22.10% |
| 2024-10-31 | $5.90 Billion | $1.75 Billion | 0.297x | -2.07% |
| 2023-10-31 | $5.84 Billion | $1.77 Billion | 0.303x | +22.58% |
| 2022-10-31 | $5.30 Billion | $1.31 Billion | 0.247x | -10.25% |
| 2021-10-31 | $5.39 Billion | $1.49 Billion | 0.276x | +45.80% |
| 2020-10-31 | $4.87 Billion | $921.00 Million | 0.189x | -12.11% |
| 2019-10-31 | $4.75 Billion | $1.02 Billion | 0.215x | -9.57% |
| 2018-10-31 | $4.57 Billion | $1.09 Billion | 0.238x | +29.33% |
| 2017-10-31 | $4.83 Billion | $889.00 Million | 0.184x | -1.60% |
| 2016-10-31 | $4.24 Billion | $793.00 Million | 0.187x | -41.23% |
| 2015-10-31 | $4.16 Billion | $1.32 Billion | 0.318x | +135.76% |
| 2014-10-31 | $5.29 Billion | $713.00 Million | 0.135x | -38.08% |
| 2013-10-31 | $5.29 Billion | $1.15 Billion | 0.218x | -8.03% |
| 2012-10-31 | $5.18 Billion | $1.23 Billion | 0.237x | -18.87% |
| 2011-10-31 | $4.32 Billion | $1.26 Billion | 0.292x | +32.68% |
| 2010-10-31 | $3.24 Billion | $712.00 Million | 0.220x | +35.14% |
| 2009-10-31 | $2.51 Billion | $408.00 Million | 0.163x | -44.89% |
| 2008-10-31 | $2.56 Billion | $756.00 Million | 0.295x | -1.40% |
| 2007-10-31 | $3.23 Billion | $969.00 Million | 0.300x | +72.92% |
| 2006-10-31 | $3.66 Billion | $634.00 Million | 0.173x | -21.34% |
| 2005-10-31 | $4.08 Billion | $899.00 Million | 0.220x | +17.35% |
| 2004-10-31 | $3.57 Billion | $670.00 Million | 0.188x | +468.15% |
| 2003-10-31 | $2.82 Billion | $-144.00 Million | -0.051x | +52.62% |
| 2002-10-31 | $4.63 Billion | $-498.00 Million | -0.108x | -140.55% |
| 2001-10-31 | $5.66 Billion | $1.50 Billion | 0.265x | +66.76% |
| 2000-10-31 | $5.26 Billion | $838.00 Million | 0.159x | +16.77% |
| 1999-10-31 | $3.38 Billion | $461.00 Million | 0.136x | -45.15% |
| 1998-10-31 | $3.02 Billion | $751.00 Million | 0.249x | -- |
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more